What is the difference between DIGOXIN and RAMIPRIL?

DIGOXIN is a Cardiac Glycoside and RAMIPRIL is a ACE Inhibitor. They reach a similar treatment goal through different pharmacological mechanisms, which is why one may be tolerated by a patient who could not tolerate the other.

Is Digoxin the same as Ramipril?

No. Digoxin (DIGOXIN) and Ramipril (RAMIPRIL) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, DIGOXIN or RAMIPRIL?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from DIGOXIN to RAMIPRIL?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

DIGOXIN vs RAMIPRIL

Compare DIGOXIN (Digoxin) and RAMIPRIL (Ramipril) — clinical data, side effects, and patient experiences.

DIGOXIN

Digoxin, Lanoxin · Cardiac Glycoside

How it works

Other agent

Approved for

while having no effect on mortality. Where possible

OralTablet

RAMIPRIL

Ramipril, Altace, Tritace · ACE Inhibitor

How it works

12.1 Mechanism of Action Ramipril and ramiprilat inhibit ACE in human subjects and animals. Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of...

Approved for

See full prescribing information

OralTablet

Quick Comparison

DIGOXINRAMIPRIL

Drug Class

Cardiac Glycoside

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DIGOXIN

Shortness of Breath

>10%

Nausea

1-10%

Dizziness

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Weakness

1-10%

Vomiting

1-10%

Low Blood Pressure

1-10%

RAMIPRIL

Shortness of Breath

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Vomiting

1-10%

Headache

1-10%

FDA Warnings

DIGOXIN

5 WARNINGS AND PRECAUTIONS Risk of rapid ventricular response leading to ventricular fibrillation in patients with AV accessory pathway
1 ) Risk of advanced or complete heart block in patients with sinus node disease and AV block
3 ) Risk of ventricular arrhythmias during electrical cardioversion
1 Ventricular Fibrillation in Patients With Accessory AV Pathway (Wolff-Parkinson- White Syndrome) Patients with Wolff-Parkinson-White syndrome who develop atrial fibrillation are at high risk of ventricular fibrillation

RAMIPRIL

WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5
3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5
, ACE inhibitors) affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving these drugs (including ramipril) may be subject to a variety of adverse reactions, some of them serious
Angioedema Head and Neck Angioedema: Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor

Community Sentiment Analysis

Based on 4 Reddit discussions

DIGOXIN

75%

positive

4 threads

RAMIPRIL

positive

0 threads

Community Discussions

4 Reddit threads analysed for DIGOXIN

Overall Sentiment

Slightly positive

Comparison Threads

Avg Post Score

30 upvotes

Patient Experiences (r/pharmacy, r/AskDocs & more)

Autoverification

Hey all, hospital pharmacist here. I work at a large hospital (level 1 trauma center/stroke center etc) that is part of a nationwide health system. We’re the second largest hospital of close to 100 hospitals, and most of the others are small community hospitals. Our health system is transitioning to

r/pharmacy57322y ago

Hospital pharmacists, what would you do?

I'm a new pharmacist (and manager) at a critical access hospital. We had a frail 84 year old patient, weighed 48 kg, CrCl 30 (at best!!!). She had CHF and aFib. Dr. ordered digoxin 500 mcg IV push. I recommended giving half the dose as a 30 min infusion, then 25% in 4-8 hours, and remaining 25% in 4

r/pharmacy31268y ago

Lets Play: Fix the Profession

Regardless of how cynical or optimistic you are, I think we can all agree that the profession of pharmacy is definitely in the "valley" portion of the employment cycle right now. Saturation is real, the major employers are abusing their employees, reimbursement is declining - things aren't looking

r/pharmacy15379y ago

Digoxin and Amiodarone Interaction

Is the 30 - 50% dose reduction of digoxin only necessary when the patient has already been on prior therapy/stabilized with digoxin and then initiated amiodarone? An input into Lexi-comp indicated that the "sequence" was important. There was a patient in the pharmacy (~60 years old; male) that was

r/pharmacy15310y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for RAMIPRIL yet.

DIGOXIN vs RAMIPRIL: What You Should Know

Key Differences

DIGOXIN is a Cardiac Glycoside, while RAMIPRIL belongs to the ACE Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

DIGOXIN carries 4 FDA warnings. RAMIPRIL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Lisinopril vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL→CAPTOPRIL AND HYDROCHLOROTHIAZIDE vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL TABLETS→CAPTOPRIL vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

DIGOXIN: DailyMed label · FAERS adverse events · ClinicalTrials.gov
RAMIPRIL: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

DIGOXIN vs RAMIPRIL

Compare DIGOXIN (Digoxin) and RAMIPRIL (Ramipril) — clinical data, side effects, and patient experiences.

DIGOXIN

Digoxin, Lanoxin · Cardiac Glycoside

How it works

Other agent

Approved for

while having no effect on mortality. Where possible

OralTablet

RAMIPRIL

Ramipril, Altace, Tritace · ACE Inhibitor

How it works

12.1 Mechanism of Action Ramipril and ramiprilat inhibit ACE in human subjects and animals. Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of...

Approved for

See full prescribing information

OralTablet

Quick Comparison

DIGOXINRAMIPRIL

Drug Class

Cardiac Glycoside

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

DIGOXIN

Shortness of Breath

>10%

Nausea

1-10%

Dizziness

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Weakness

1-10%

Vomiting

1-10%

Low Blood Pressure

1-10%

RAMIPRIL

Shortness of Breath

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Vomiting

1-10%

Headache

1-10%

FDA Warnings

DIGOXIN

5 WARNINGS AND PRECAUTIONS Risk of rapid ventricular response leading to ventricular fibrillation in patients with AV accessory pathway
1 ) Risk of advanced or complete heart block in patients with sinus node disease and AV block
3 ) Risk of ventricular arrhythmias during electrical cardioversion
1 Ventricular Fibrillation in Patients With Accessory AV Pathway (Wolff-Parkinson- White Syndrome) Patients with Wolff-Parkinson-White syndrome who develop atrial fibrillation are at high risk of ventricular fibrillation

RAMIPRIL

WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5
3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5
, ACE inhibitors) affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving these drugs (including ramipril) may be subject to a variety of adverse reactions, some of them serious
Angioedema Head and Neck Angioedema: Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor

Community Sentiment Analysis

Based on 4 Reddit discussions

DIGOXIN

75%

positive

4 threads

RAMIPRIL

positive

0 threads

Community Discussions

4 Reddit threads analysed for DIGOXIN

Overall Sentiment

Slightly positive

Comparison Threads

Avg Post Score

30 upvotes

Patient Experiences (r/pharmacy, r/AskDocs & more)

Autoverification

r/pharmacy57322y ago

Hospital pharmacists, what would you do?

r/pharmacy31268y ago

Lets Play: Fix the Profession

r/pharmacy15379y ago

Digoxin and Amiodarone Interaction

r/pharmacy15310y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for RAMIPRIL yet.

DIGOXIN vs RAMIPRIL: What You Should Know

Key Differences

Safety Considerations

DIGOXIN carries 4 FDA warnings. RAMIPRIL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.